Outcomes of Alcohol Septal Ablation in Younger Patients With Obstructive Hypertrophic Cardiomyopathy-Reference-Cited by-同舟云学术

Outcomes of Alcohol Septal Ablation in Younger Patients With Obstructive Hypertrophic Cardiomyopathy

Published:2017-06 Issue:11 Volume:10 Page:1134-1143
ISSN:1936-8798
Container-title:JACC: Cardiovascular Interventions
language:en
Short-container-title:JACC: Cardiovascular Interventions

Author:

Liebregts Max,Faber Lothar,Jensen Morten K.,Vriesendorp Pieter A.,Januska Jaroslav,Krejci Jan,Hansen Peter R.,Seggewiss Hubert,Horstkotte Dieter,Adlova Radka,Bundgaard Henning,ten Berg Jurriën M.,Veselka Josef

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference21 articles.

1. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy;Sigwart;Lancet,1995

2. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines;Gersh;J Am Coll Cardiol,2011

3. Long-term outcomes after medical and invasive treatment in patients with hypertrophic cardiomyopathy;Vriesendorp;J Am Coll Cardiol HF,2014

4. The long-term outcomes of transcoronary ablation of septal hypertrophy compared to surgical myectomy in patients with symptomatic hypertrophic obstructive cardiomyopathy;Samardhi;Catheter Cardiovasc Interv,2014

5. Long-term outcomes of septal reduction for obstructive hypertrophic cardiomyopathy;Sedehi;J Cardiol,2015

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transapical beating-heart septal myectomy for hypertrophic cardiomyopathy patients with midventricular obstruction;Heliyon;2024-05

2. Clinical characteristics and outcomes of alcohol septal ablation in the era of transcatheter valve interventions;Catheterization and Cardiovascular Interventions;2024-04-19

3. Interventions in Hypertrophic Obstructive Cardiomyopathy;Canadian Journal of Cardiology;2023-12

4. Invasive therapies for symptomatic obstructive hypertrophic cardiomyopathy;Progress in Cardiovascular Diseases;2023-09

5. 2023 ESC Guidelines for the management of cardiomyopathies;European Heart Journal;2023-08-25